These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28988693)
21. Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer. Blok EJ; van den Bulk J; Dekker-Ensink NG; Derr R; Kanters C; Bastiaannet E; Kroep JR; van de Velde CJ; Kuppen PJ Oncotarget; 2017 Feb; 8(9):15610-15620. PubMed ID: 28121628 [TBL] [Abstract][Full Text] [Related]
22. Altered CD8(+) T-cell counts as an early predictor of prognosis in critically ill immunocompromised patients with invasive pulmonary aspergillosis. Cui N; Wang H; Long Y; Liu D Chin Med J (Engl); 2014; 127(1):36-42. PubMed ID: 24384421 [TBL] [Abstract][Full Text] [Related]
23. [Immunological balance of CD8 Dai SX; Gu HX; Wu G; Zhong T; Jian HJ; Zhan YL; Zhang MH; Gao Y; Xu J; Chen DS; Liao GJ; Feng YL; Liu HB; Zou Y; Chi HG Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1609-1615. PubMed ID: 27998853 [TBL] [Abstract][Full Text] [Related]
24. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer. Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145 [TBL] [Abstract][Full Text] [Related]
25. CD8 Zhang L; Wang Z; Wang D; Zhu J; Wang Y Mol Immunol; 2018 Sep; 101():74-79. PubMed ID: 29886399 [TBL] [Abstract][Full Text] [Related]
26. [Predictive and prognostic value of monitoring lymphocyte subsets in peripheral blood before and after chemotherapy in patients with metastatic breast cancer]. Shao B; Li HP; DI LJ; Song GH; Jiang HF; Liang X; Wang CY; Yan Y; Lin XL; Wang LN; Wan FL; Yuan YH; You MN Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):304-9. PubMed ID: 27080286 [TBL] [Abstract][Full Text] [Related]
27. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. Banys-Paluchowski M; Fehm T; Janni W; Aktas B; Fasching PA; Kasimir-Bauer S; Milde-Langosch K; Pantel K; Rack B; Riethdorf S; Solomayer EF; Witzel I; Müller V BMC Cancer; 2018 May; 18(1):541. PubMed ID: 29739347 [TBL] [Abstract][Full Text] [Related]
28. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses. He J; Duan S; Yu X; Qian Z; Zhou S; Zhang Z; Huang X; Huang Y; Su J; Lai C; Meng J; Zhou N; Lu X; Zhao Y Theranostics; 2016; 6(5):752-61. PubMed ID: 27022421 [TBL] [Abstract][Full Text] [Related]
29. Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments. Zhao YJ; Jiang N; Song QK; Wu JP; Song YG; Zhang HM; Chen F; Zhou L; Wang XL; Zhou XN; Yang HB; Ren J; Lyerly HK Asian Pac J Cancer Prev; 2015; 16(6):2419-23. PubMed ID: 25824775 [TBL] [Abstract][Full Text] [Related]
30. Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer. Li M; Xu J; Jiang C; Zhang J; Sun T Front Oncol; 2022; 12():842705. PubMed ID: 35242718 [TBL] [Abstract][Full Text] [Related]
31. The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model. Li N; Ji PY; Song LG; Lei JX; Lv ZY; Wu ZD; Shao X; Sun X Parasitol Res; 2015 Aug; 114(8):3047-58. PubMed ID: 26002824 [TBL] [Abstract][Full Text] [Related]
32. Elevated T cell activation score is associated with improved survival of breast cancer. Lu L; Bai Y; Wang Z Breast Cancer Res Treat; 2017 Aug; 164(3):689-696. PubMed ID: 28488141 [TBL] [Abstract][Full Text] [Related]
33. Numerical and functional defects in CD8 Li H; Hao Y; Zhang D; Liu W; Li Y; Lyu M; Fu R; Xue F; Liu X; Yang R Br J Haematol; 2017 Jul; 178(2):292-301. PubMed ID: 28466476 [TBL] [Abstract][Full Text] [Related]
34. [Value of CD8(+) T lymphocyte subgroups for the predication of pulmonary invasive fungal infections in immunocompromised critically ill patients]. Cui N; Liu DW; Wang H; Long Y; Liu Y; Ding X; Zhou X; Rui X Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1253-8. PubMed ID: 22883063 [TBL] [Abstract][Full Text] [Related]
35. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer. Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study. Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640 [TBL] [Abstract][Full Text] [Related]
37. Invasive Fungal Disease in Critically Ill Patients at High Risk: Usefulness of Lymphocyte Subtyping. Zhang J; Cui N; Wang H; Han W; Li Y; Xiao M; Liu D J Intensive Care Med; 2020 Sep; 35(9):909-918. PubMed ID: 30231674 [TBL] [Abstract][Full Text] [Related]
38. [Prognostic value of T lymphocytes infiltration in breast cancer]. Yu HM; Jiao SC; Yang JL; Wang JD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010 [TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy. Li N; Gao L; Ge Y; Zhao L; Bai C; Wang Y Front Oncol; 2023; 13():1195848. PubMed ID: 37346066 [TBL] [Abstract][Full Text] [Related]
40. Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer. de Gast GC; Vyth-Dreese FA; Nooijen W; van den Bogaard CJ; Sein J; Holtkamp MM; Linthorst GA; Baars JW; Schornagel JH; Rodenhuis S J Clin Oncol; 2002 Jan; 20(1):58-64. PubMed ID: 11773154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]